Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11: In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids
Overview
Authors
Affiliations
Axillary osmidrosis (AO) is a common chronic skin condition characterized by unpleasant body odors emanating from the armpits, and its aetiology is not fully understood. AO can seriously impair the psychosocial well-being of the affected individuals; however, no causal therapy has been established for it other than surgical treatment. Recent studies have revealed that human ATP-binding cassette transporter C11 (ABCC11) is an AO risk factor when it is expressed in the axillary apocrine glands-the sources of the offensive odors. Hence, identifying safe ways to inhibit ABCC11 may offer a breakthrough in treating AO. We herein screened for ABCC11-inhibitory activities in 34 natural products derived from plants cultivated for human consumption using an in vitro assay system to measure the ABCC11-mediated transport of radiolabeled dehydroepiandrosterone sulfate (DHEA-S-an ABCC11 substrate). The water extract of soybean () was found to exhibit the strongest transport inhibition. From this extract, via a fractionation approach, we successfully isolated and identified genistein, a soy isoflavone, as a novel ABCC11 inhibitor with a half-maximal inhibitory concentration value of 61.5 μM. Furthermore, we examined the effects of other dietary flavonoids on the ABCC11-mediated DHEA-S transport to uncover the effects of these phytochemicals on ABCC11 function. While further human studies are needed, our findings here about the natural compounds will help develop a non-surgical therapy for AO.
Functional characterization of variants in human ABCC11, an axillary osmidrosis risk factor.
Toyoda Y, Matsuo H, Takada T Hum Cell. 2024; 37(4):1070-1079.
PMID: 38750405 DOI: 10.1007/s13577-024-01074-x.
Yang B, Xin M, Liang S, Xu X, Cai T, Dong L Front Pharmacol. 2022; 13:1026246.
PMID: 36483739 PMC: 9723165. DOI: 10.3389/fphar.2022.1026246.
Toyoda Y, Takada T, Saito H, Hirata H, Ota-Kontani A, Tsuchiya Y Nutrients. 2022; 14(3).
PMID: 35276934 PMC: 8839210. DOI: 10.3390/nu14030575.
Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.
Namasivayam V, Stefan K, Pahnke J, Stefan S Comput Struct Biotechnol J. 2022; 19:6490-6504.
PMID: 34976306 PMC: 8666613. DOI: 10.1016/j.csbj.2021.11.035.